Montse Bonas-Janssen

St. Antonius Hospital
Nieuwegein, UT 3435CM, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Drivers of Methotrexate Polyglutamate Concentration in Erythrocytes: Insights from Immune-Mediated Inflammatory Diseases and Pediatric Acute Lymphoblastic Leukemia.

Drivers of Methotrexate Polyglutamate Concentration in Erythrocytes: Insights from Immune-Mediated Inflammatory Diseases and Pediatric Acute Lymphoblastic Leukemia.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: December 11, 2025

First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate.

First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate.

Journal: The New England journal of medicine

Published: May 19, 2025

Mycobacterium tuberculosis-specific blood immune signatures distinguish sarcoidosis from tuberculosis disease.

Mycobacterium tuberculosis-specific blood immune signatures distinguish sarcoidosis from tuberculosis disease.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: March 27, 2025

Targeted proteomics in extracellular vesicles identifies biomarkers predictive for therapeutic response in sarcoidosis.

Targeted proteomics in extracellular vesicles identifies biomarkers predictive for therapeutic response in sarcoidosis.

Journal: ERJ open research

Published: July 04, 2024

Decreased serpin C1 in extracellular vesicles predicts response to methotrexate treatment in patients with pulmonary sarcoidosis.

Decreased serpin C1 in extracellular vesicles predicts response to methotrexate treatment in patients with pulmonary sarcoidosis.

Journal: Respiratory research

Published: November 03, 2023

Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study.

Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study.

Journal: Lung

Published: September 11, 2023

Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases.

Prevalence and clinical associations of myositis antibodies in a large cohort of interstitial lung diseases.

Journal: PloS one

Published: May 10, 2022

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.

Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study.

Journal: BMC pulmonary medicine

Published: September 09, 2020

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease.

Prevalence of Novel Myositis Autoantibodies in a Large Cohort of Patients with Interstitial Lung Disease.

Journal: Journal of clinical medicine

Published: June 29, 2020

Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.

Journal: Frontiers in immunology

Published: April 08, 2020

CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide.

CD24(hi)CD27(+) B cells from patients with allergic asthma have impaired regulatory activity in response to lipopolysaccharide.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: November 26, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026